$IQV

Iqvia Holdings Inc.

NYSE · Healthcare · Services-Commercial Physical & Biological Research · Durham, NC

IQV chart

What traders are saying about $IQV

Latest posts

Iqvia Holdings Inc. news

Iqvia Holdings Inc. key financials

USD2025202420232022
Revenue$16.31B$15.40B$14.98B$14.41B
Net income$1.36B$1.37B$1.36B$1.09B
Diluted EPS$7.84$7.49$7.29$5.72
Total assets (year end)$29.94B$26.90B$26.68B$25.34B
Cash and equivalents (year end)$1.98B$1.70B$1.38B$1.22B

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K

About Iqvia Holdings Inc.

Ticker
IQV (NYSE)
Industry
Services-Commercial Physical & Biological Research
Headquarters
Durham, NC
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1478242
Former names
Quintiles IMS Holdings, Inc., Quintiles Transnational Holdings Inc.

Frequently asked questions

What exchange is Iqvia Holdings Inc. listed on?

Iqvia Holdings Inc. trades on the NYSE under the ticker symbol IQV.

What industry is Iqvia Holdings Inc. in?

Iqvia Holdings Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.

Where is Iqvia Holdings Inc. headquartered?

Iqvia Holdings Inc.'s business address on file with the SEC is in Durham, NC.

When does Iqvia Holdings Inc.'s fiscal year end?

Iqvia Holdings Inc.'s fiscal year ends on December 31.

How much revenue did Iqvia Holdings Inc. report?

Iqvia Holdings Inc. reported $16.31B in revenue for calendar year 2025, according to its SEC filings.